Asia Pacific Radiation Oncology Market Size, Share & Industry Trends Analysis Report By Application, By Type (External Beam Radiation Therapy and Internal Beam Radiation Therapy), By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Radiation Oncology Market is expected to witness market growth of 9.4% CAGR during the forecast period (2022-2028).

Between 1920 and 1945, technological advancements were concentrated on increasing beam production and energy. The use of radiation for deep tumors was constrained by the low energy (200-500 kV) of x-rays utilized at the time, which were linked to skin damage due to inadequate penetration. A crucial advancement was the creation of Cobalt-60 units and linear accelerators in the 1950s to deliver "super voltage" radiation energies (1 MeV), which could penetrate deeper to target deeper-seated malignancies.

Fractionated therapy, which extends back to the 1920s, separates treatment into numerous little radiation doses rather than one massive dose and has enabled normal tissues to tolerate treatment more effectively. The science of radiation oncology has been moving towards the desired objective of non-invasively attaining maximal local cancer control with minimal normal tissue harm as technology, imaging, and cancer biology advancements throughout the following decades.

According to the National Health and Family Planning Commission (NHFPC), the 2016 health budget is 1.24 trillion yuan, with medical spending growing at an average annual pace of more than 20% over the previous seven years. According to the commission, the ultimate goal of healthcare reform is to establish a national health security system that is centered on ensuring that everyone has fair access to basic public health services. Additionally, county-level or higher hospital emergency reform and repairs are supported by the budget.

The China market dominated the Asia Pacific Radiation Oncology Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $1,017.8 million by 2028.The Japan market is estimated to grow a CAGR of 8.8% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 10.1% during (2022 - 2028).

Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Breast Cancer
• Gynecological Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Head & Neck Cancer
• Gynecological Cancer
• Others

By Type

• External Beam Radiation Therapy
• Internal Beam Radiation Therapy

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Becton, Dickinson and Company
• Varian Medical Systems, Inc.
• Ion Beam Applications SA
• Elekta AB
• Accuray Incorporated
• Nordion Inc. (Sotera Health LLC)
• Isoray Inc.
• Mevion Medical Systems, Inc.
• Provision Healthcare
• Panacea Medical Technologies Pvt. Ltd.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free